Evidence map›Paper›PMID 39155964›Full record

ArticleFarmaceuticos comunitarios2023

[Complexity of diagnosis and treatment of neuropathic pain].

Gema Martínez Escrivá, Teresa López de Coca Pérez, Lucrecia Moreno Royo

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Farmaceuticos comunitarios, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gema Martínez EscriváCátedra DeCo MICOF-CEU UCH, Universidad Cardenal Herrera CEU, CEU Universities, Valencia, Spain Universidad Cardenal Herrera CEU España.
Teresa López de Coca PérezCátedra DeCo MICOF-CEU UCH, Universidad Cardenal Herrera CEU, CEU Universities, Valencia, Spain Universidad Cardenal Herrera CEU España.
Lucrecia Moreno RoyoCátedra DeCo MICOF-CEU UCH, Universidad Cardenal Herrera CEU, CEU Universities, Valencia, Spain Universidad Cardenal Herrera CEU España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fifty-six years old woman who had neurological health problems for 5 years since she suffered a traffic accident. She was diagnosed with parkinsonism. She came to the community pharmacy for information on screening for cognitive impairment because she reported frequent forgetfulness.A pharmacotherapeutic evaluation of the treatment was carried out following the Dader methodology and the anticholinergic load (AC) of the medication was studied. According to the anticholinergic scale, the patient presented an AC of 3.25, which can be related to the appearance of adverse effects such as cognitive alterations. As her pain was not controlled, she was brought back to the physician to try to achieve an effective treatment. A functional neurological disorder and major depressive disorder were confirmed. With the new medication, the AC decreased to 1.The treatment of neuropathic pain is complex and accurate diagnosis is important for effective treatment. Although, symptomatology often leads to misdiagnosis and treatment with drugs that are not effective in solving the problem and can lead to adverse reactions as in this situation. In these patients, it is necessary to reevaluate the treatment and their cognitive status periodically.

Indexed as

anticholinergics loadchronic paincommunity pharmacyParkinson’s diseasetherapeutic adherence

Identifiers

PMID39155964
PMCPMC11328699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.